Tiger Jade Capital is a Private Equity fund focused on China’s Health Care industry. It is a comprehensive health care fund covering new drug, CRO, medical equipment, etc areas. It is initiated by China’s leading CRO Company Tigermed (Shenzhen stock: 300347) and ex-partner of Capital Today Mr. Jiang. Tiger Jade Capital aspires to aggregate conscious capital to improve people’s well being and contribute to community with full dedication and integrity; and as a result, deliver optimal return for our investors.